HomeREGULATORY
REGULATORY

Annual Re-Pricing Likely to Start in FY2021 for Scope of Products Defined in 2020
(Nov.17.2017)

The Japanese government is likely to introduce a new annual drug price survey/re-pricing cycle in FY2021, which begins in April 2021, for a scope of products that would be defined by the end of 2020, Jiho has learned ...
(LOG IN FOR FULL STORY)

News Calendar